RAPP
Rapport Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report0 of 7 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Largest filed tie
—
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | FMRFMR | $298.9M | 13.99% | +0.06% | |
| 2 | TRV GP VTRV GP V | $261.7M | 12.25% | −11.98% | |
| 3 | Arch VentureArch Venture | $155.4M | 7.27% | 0.00% | |
| 4 | Capital International InvestorsCapital International Investors | $121.8M | 5.70% | −5.68% | |
| 5 | Goldman Sachs GroupGoldman Sachs | $121.3M | 5.67% | −1.08% | |
| 6 | BlackRockBlackRockindex-like | $112.5M | 5.26% | +7.73% | |
| 7 | Cormorant Asset ManagementCormorant | $110.7M | 5.18% | −10.14% | |
| 8 | Sofinnova InvestmentsSofinnova | $79.4M | 3.71% | 0.00% | |
| 9 | Johnson & JohnsonJohnson & Johnson | $74.4M | 3.48% | 0.00% | |
| 10 | Polar Capital HoldingsPolar Capital | $67.0M | 3.14% | −2.07% | |
| 11 | Baker Bros. AdvisorsBaker Bros. | $64.5M | 3.02% | 0.00% | |
| 12 | Vanguard Capital ManagementVanguardindex-like | $56.1M | 2.63% | +1.62% | |
| 13 | TRV GP VITRV GP VI | $40.4M | 1.89% | 0.00% | |
| 14 | State StreetState Streetindex-like | $34.1M | 1.60% | +7.79% | |
| 15 | Geode Capital ManagementGeodeindex-like | $33.1M | 1.55% | +9.95% | |
| 16 | T. Rowe Price AssociatesT. Rowe Price | $32.8M | 1.54% | −9.12% | |
| 17 | Perceptive AdvisorsPerceptive | $32.2M | 1.51% | +14.75% | |
| 18 | Vestal Point CapitalVestal Point Capital | $30.4M | 1.42% | −49.17% | |
| 19 | AlliancebernsteinAlliancebernstein | $28.9M | 1.35% | −4.73% | |
| 20 | UBS Asset Management AmericasUBS Asset Management Americas | $26.8M | 1.26% | −29.90% | |
| 21 | SirenSiren | $26.7M | 1.25% | 0.00% | |
| 22 | Capital World InvestorsCapital World Investors | $23.0M | 1.08% | +2.80% | |
| 23 | T. Rowe Price Investment ManagementT. Rowe Price | $16.4M | 0.77% | −36.64% | |
| 24 | Dimensional Fund AdvisorsDimensional | $15.1M | 0.71% | +61.30% | |
| 25 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $15.0M | 0.70% | +12.16% |
160 managers report $2.1B of Rapport Therapeutics on form 13F for the quarter ended Jun 30 '26. 18 of them hold 80% of it; FMR is largest at 13.99%.
No implied move.
No implied move.
Expected move
No implied move.
Rapport Therapeutics, Inc.
25.06
+0.85 · +3.50%
post 24.57 −1.95%